| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.23 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |